// App-Quantinova.ai

Tu1179 : Colorectal Cancer Screening Program in the Ontario Population: the Additional Effects of Identifying Individuals With an Increased Risk

Researchers

Presenter

  • Linda Rabeneck

Principal Investigators

  • Iris Lansdorp-Vogelaar

  • Ann G. Zauber

  • Lawrence Paszat

  • Jeffrey S. Hoch

  • Jean H. Yong

  • Marjolein van Ballegooijen

Medical Centers

  • Memorial Sloan Kettering Cancer Center, Port Washington, NY

  • Institute of Clinical Evaluative Sciences, Toronto, ON, Canada

  • Department of Pathology, Erasmus MC University Medical Center ENSAT, Rotterdam, Netherlands

  • Cancer Care Ontario, Toronto, ON, Canada

Locations

  • United States

  • Canada

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim